Related Experiment Video
Updated: Mar 1, 2026
07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
1.0K
Targeting PAR1: Now What?
Robert Flaumenhaft1, Karen De Ceunynck1
1Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Trends in Pharmacological Sciences
|June 1, 2017
Summary
Next-generation protease-activated receptor 1 (PAR1) therapeutics show promise. Despite past challenges with PAR1 drugs, new insights into PAR1 function and novel therapeutic strategies offer renewed opportunities for effective treatments.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Protease-activated receptors (PARs) are GPCRs mediating cellular responses to proteases.
- PAR1, the first identified PAR, has been a focus of drug development since the 1990s.
- Approved PAR1 therapeutics (vorapaxar, drotrecogin-alfa) faced clinical limitations due to safety and efficacy concerns.
Purpose of the Study:
- To critically evaluate the prospects for next-generation PAR1-targeted therapeutics.
- To review new understanding of PAR1 function and novel strategies for PAR1 modulation.
- To identify emerging indications for PAR1-based therapies.
Main Methods:
- Literature review of PAR1 research and drug development.
- Analysis of mechanisms underlying PAR1 function and modulation.
- Evaluation of clinical data and therapeutic outcomes for PAR1-targeted drugs.
Main Results:
- Past PAR1 therapeutics (vorapaxar, drotrecogin-alfa) have shown limited clinical utility.
- Advances in understanding PAR1 signaling pathways have been made.
- Novel strategies for modulating PAR1 activity are emerging.
Conclusions:
- Despite previous setbacks, renewed research offers significant opportunities for developing effective PAR1-targeted therapies.
- Future PAR1 therapeutics may overcome limitations of earlier drugs.
- Targeting PAR1 remains a promising avenue for novel therapeutic interventions.
More Related Videos
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.5K
01:21Paracrine Signaling
60.0K
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
60.0K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
01:30Parasympathetic Signaling
3.6K
Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
The effects of...
3.6K
01:25Dose-Response Relationship: Selectivity and Specificity
10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K